Neurokinin 3 Receptor Antagonism Rapidly Improves Vasomotor Symptoms With Sustained Duration of Action

(Abstracted from Menopause 2018;25(8):862–869) Approximately 70% of postmenopausal women experience vasomotor symptoms, and 10% describe these symptoms as intolerable. Conventional treatment of hot flashes (HFs) includes hormone therapy and other alternative treatments; however, these treatments have mixed responses, variable availability, and can be contraindicated in some women such as those with a history of breast cancer.
Source: Obstetrical and Gynecological Survey - Category: OBGYN Tags: GYNECOLOGY: MENOPAUSE Source Type: research